The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus

Abstract

There was a trend towards a more favourable outcome associated with the use of PES over BMS. There was no significant difference between SES and PES in each of the clinical endpoints, and neither in the NIDDM patients, which are hypothesized to be better-off with PES.